A discussion about dark net terminology

As a social scientist, I continue to be interested in understanding the intersections between internet technologies and psychoactive drugs, especially drugs that are otherwise difficult to obtain due to prohibition. These intersections are numerous: the internet can facilitate drug trades, information exchange, and safe spaces for communication between like-minded people. While all of the above occurred prior to ubiquitous internet use, current digital technologies lubricate these existing processes making them quicker, easier and more efficient, changing the scale of what is possible.

One enduring problem I have noticed when discussing these issues is a lack of clarity about terminology. This lack of clarity can lead to serious problems in logic and argument.

An example of this problem can be found in reporting by the Australian TV program 60 minutes from 2014, as described at AllThingsVice. In this program, the terms ‘deep web’ and ‘dark web’ were conflated. This conflation led to the reporters claiming that the dark web was 90% of the total content of the web, when in fact, it is many magnitudes smaller than the surface web. This conflation suited the tone of this story as it supported the scaremongering: making the dark web threat appear very large. Nevertheless the lack of shared definitions of terms makes this space harder to understand and easier to misrepresent.

I am by no means the definitive expert on all things dark net. What follows are my thoughts on what I believe we are talking about. I include here my sense of doubt and ambiguities that I believe exist regarding terminology and definitions of internet structures that surround or are present in the dark net. I invite your comments and hopefully these may lead to a more definitive document, although I doubt you can ever get ‘the internet’ to agree entirely on anything!

If we consider ‘the web’, that is, all of the content accessible through browsers connected to the Internet, we can divide the web into two parts: (1) the surface web, (2) the deep web. All content that can be accessed through search engines is the surface web. The remaining web content is the deep web: which we can define as content inaccessible via search engines. These terms and definitions were first used by Bergman in 2001. In his calculations the deep web was many magnitudes larger than the surface web, which he represented with an iceberg image, the surface web being just the tip of the iceberg of web content available. We are nearly 15 years on from this original formulation, so I have no idea the scale of content the web now contains. A very large number I’m sure!

So, what is contained within the deep web? Some examples include: content that is locked behind pay-walled websites, content accessible through company or academic databases, any kind of database that cannot be searched directly by Google, websites that are not linked to other websites, private websites and forums, etc. An example of typical deep web content is the results of a search for accommodation using a travel website. This content can only be accessed after a text search, which is something a search engine cannot do. A vast amount of website content can, therefore, not be indexed by clicking on links, and this is the deep web.

A small part of the deep web content includes hidden internet services, usually accessible through Tor but also through alternative anonymising software like I2P. By its users, this part of the internet is called the dark net. The terminology ‘dark’ refers to the difficulty finding the content rather than its nature being dark: content in the dark web is being intentionally hidden. The term dark net and the term dark web are often used interchangeably. According to wikipedia, a darknet is a private peer-to-peer network, but it also appears to be the term most currently used by hidden internet service communities to describe their world. For example, darknetstats, r/darknetmarkets, etc.

Dark net markets are digital platforms that use anonymising software (e.g. Tor) and cryptocurrencies (e.g. Bitcoin) to facilitate trade of goods and services. These marketplaces have also been called cryptomarkets (coined by James Martin) because they would not be possible without the use of cryptography. Dark net markets or cryptomarkets are a subset of the dark net or dark web; the dark net/web is a subset of the deep web; and the deep web is a subset of the entire web. The deep web is all content that is not classified as the surface web, but it appears that the terms surface web and clear web / clear net are used interchangeably to refer to the same thing: web content accessible via search engines. Perhaps at some point the clear / dark distinction was binary, in that the dark web represented everything that the clear web was not.

An interesting point was made in conversation with Rasmus Andersen on the above distinctions. He noted that it is in fact more difficult to access paywalled content in the deep web than it is to access dark net markets, because there are many access points in the surface web that lead there, even without the need to install Tor. For example, tor2web can be used as a gateway into dark net markets without actually using Tor, although this would not be a secure option. Many of the sites that track the development of dark net markets are also hosted in the clear web: deepdotweb and r/darknetmarkets, for example. So, although content from dark net markets is not directly indexed by search engines (at least clear web search engines, cf. dark net market search engine Grams), entry points into dark net markets abound in the clear net. A simple Google search can mean you are not far away from entering a dark net market. But as I’ve outlined previously, it takes more than entering the marketplace to make a successful purchase!

Here are some helpful related links:

Hacker Lexicon: What Is the Dark Web? by Andy Greenberg

Clearing up confusion – deep web vs. dark web by Bright Planet

Thanks to those involved in prior discussions on the Cryptomarket Research e-list. The above is provisional so tell me what you think in the comments.

Letter to Nash and Dutton re defunding ADCA

My email to Senator Nash and MP Peter Dutton:

Dear Ms Nash and Mr Dutton

I was shocked to discover that the ADCA has been defunded by your government. I am a research fellow specialising in alcohol and other drug research – my work has recently been recognised by an early career research fellowship through the National Health and Medical Research Council. I have been a member of the ADCA since 2003, when I first began working in this field. I regularly use their services and participate in their events, which enable the broader public to be better informed about drug/alcohol issues. These issues touch the lives of almost everyone in our community. I am astonished that your government does not see the value in such an organisation with a 50 year history, an organisation that is highly valued by everyone in our field.

I would ask you to reconsider your decision. For what is a relatively small amount of funding, this group does a lot of good work, and is supported by paid members like myself, so is not entirely dependent on your funding (therefore bringing greater value for money than a fully funded council). I see this decision as very short-sighted, because by reducing the government commitment to ADCA, you will very likely be increasing the burden of alcohol/drug issues in the community, therefore increasing the costs of managing such problems down the track. Prevention is better than cure, and it is also less costly for the budget. I would hope you would see this logic when consider budgetary matters rather than looking for short-term cuts.

Yours sincerely,



The problem with banning

Edit: You can listen to a version of this post here: Link to 1233 Newcastle clip

Tragically, we have seen another teen (Henry Kwan) die after consuming what he believed to be LSD, but which was actually an NBOMe (e.g. 25I-NBOMe), which is a much newer and more potent psychedelic substance. At the same time the NSW Fair Trading Department has banned a list of products that contain synthetic analogue drugs and has raided stores across that state.

I was asked onto ABC Radio in Newcastle this morning for my view on this issue and this is a summary of what I said:

The problem with banning is that banning is one of the major causes of this problem in the first place.

To take the example of cannabis, we currently prohibit the use of cannabis, although if someone is caught with personal use amounts of cannabis, they will either be fined or diverted for first offences across Australia. Even so, people know that it is illegal and that it is an offence. And many people care deeply about that. They want to be able to consume cannabis and not worry at all about being caught, to be able to do it legally, to know that they can enjoy a weekend spliff just like others enjoy a weekend beer, without having to worry about losing their job because a drug test is positive for past cannabis use.

So when these people are made aware of a new so-called legal weed, the synthetic cannabis products, they are interested. Maybe they can finally enjoy the cannabis like high without having to worry about the legality.

So you can see that prohibition of cannabis largely drives these people’s attraction to synthetic cannabis products.

Over the last couple of years we have seen some of the health harms that have arisen from people switching from natural to synthetic – including withdrawal, dependence, psychosis, seizures. Now, I’m not saying plant based cannabis is harmless, but it has been proven to have medicinal pain relieving qualities. At least we know a lot more about cannabis and its many constituents, we have been doing research for many decades and it has been used by humans for millenia. This is the opposite for the vast number of synthetic cannabinoids which we know very little about. Therefore, I think it is reasonable to conclude that if someone is going to use one product or the other, natural plant-based cannabis is a better choice, a healthier choice. Yet, our policies seem to be pushing people towards the lesser choice, the choice we know less about, and which appears to be associated with more harmful effects – that is, the synthetic cannabis products.

We need to ask: what is drug policy about? Is it about helping people to reduce drug harms, by nudging them towards less harmful options? Or is it about putting our head in the sand and thinking we can eliminate all drug use somehow, while at the same time, nudging people who consume drugs towards more harmful options? Or is it not about harms at all… but rather, about the appearance of doing something in the eyes of the voting public?

I think we need to have a serious discussion about what we want from our drug policies and what we value in Australia when it comes to drug use, something almost all of us do when you consider that alcohol, caffeine and pain medications are also psychoactive drugs.

I would suggest that Australia needs to join the global discussion about alternatives to the prohibition model. That doesn’t mean that we move to legalisation of all drugs – there are a lot of different models of regulation we could consider. But the very first step is to acknowledge that we have a problem and that we need to consider solutions. Until the Australian public and our governments and our other officials in police, justice, health and social sectors publicly acknowledge that the current system is broken, anyone who tries to start this discussion is labelled as radical. These issues are complex and they require strong leadership of a public discussion that opens up our assumptions to full scrutiny.

Buying on Silk Road

In this post, I’m going to write up the process of buying something on Silk Road. The first thing to note is that the item I bought was not an illicit drug, otherwise I’d hardly be detailing the process on a public and identified blog. Rather, my purpose was ethnographic – if I am to study how the SR marketplace works, taking part in aspects of it is a useful learning tool. Reading an account of something, or listening to someone’s story, is one way of learning. Another way is to try it for yourself – and as I usually find, self-experience can result in learnings that you can’t necessarily predict!

Browsing the SR marketplace for items which were legal and which I would otherwise have bought led me to the Apparel section of the site. Although best know for its selection of psychoactive substances, SR also sells a wide range of goods and some services. In the Apparel section, I found jackets, bags, jeans, sunglasses, jewelery. Many of these listings were for faked designer goods, as opposed to stolen goods. I thought to myself that if I were in South East Asia on holiday and bought myself some ‘fake’ designer clothing, I wouldn’t get stopped at the Australian border and strip-searched. Almost all Australians I know will buy these much cheaper faked goods when overseas. So this appeared to be a good option for a ‘legal’ SR purchase.

If only I'd bought them for this price!
An example of FoxyGirl’s offerings

From the would-be buyers perspective, it is important to get a sense of the trustworthiness of the vendor you are considering purchasing from. The item I liked the look of the best was FoxyGirl’s replica [insert designer name here] sunglasses. So I checked out FoxyGirl’s reputation. Searching for her name in the forums led me to her review thread, where I found links to her Tor ‘gallery’ of items for sale, and comments by other SR members who seemed satisfied with their purchases. One comment I found read:

Grabbed some [insert designer name here] from foxy and holy hell! I put em up next to my real ones and honestly, cant really tell they are fake at all. really good replicas!
shipping was super fast and very well packaged might I add! Thanks so much foxygirl! will be grabbing more stuff very very soon!

I then read carefully through FoxyGirl’s terms and conditions and her feedback, which was positive. She seemed like a friendly salesperson, willing to help. But most of the vendor profiles seem to be written in that way. I then messaged FoxyGirl to ask her for some more details about the sunglasses, and really just to suss out her legitimacy. True to her word, she got back to me with further information and in a professional yet friendly style.

At this point I was convinced – I was going to buy these sunglasses. Of course, in order to complete the transaction, I needed to have enough Bitcoin in my SR account.

Back in March, I decided to bite the bullet and buy $300 AUD of Bitcoin. I chose a time when the market was pricing BTC at $147 AUD per coin. I traded with a friend I met at a local #cryptoparty who had a listing on Bitcoin-OTC. In fact once I knew this guy and he taught me how to use encryption, buy BTC from him was as simple. First, I downloaded Bitcoin-QT, the original wallet software (this takes a few days due to the size of the blockchain which must be constantly updated to keep the network in-sync). Then, my friend sent me his bank details (encrypted, of course). I then deposited $300 in his bank account, taking a screenshot of the transaction as evidence. He promptly transferred me the equivalent in Bitcoin minus a small commission for his efforts. I then had 1.9 BTC.

One of the oddities about this context of buying with BTC which I had not anticipated was that since I bought them in March for $147 per coin, they continued to appreciate in value until they were worth over $250 each coin! During this time, I was meaning to buy my sunglasses but each day that passed, the price in BTC was getting lower and lower as the BTC value increased. I found that I didn’t want to purchase because what if tomorrow the price was even lower? This experience of wanting to hoard rather than buy is not something we are used to experiencing when using an inflationary currency, e.g. the AUD or the USD.

Of course I was a victim of my own greed. On April 11, BTC value plunged and suddenly my sunglasses were much more expense! If only I’d bought them when the BTC was valued at $250… Sigh! In fact, what actually happened was that I had decided to buy the sunglasses on April 10, and so I made a transfer from my local wallet to my SR wallet of .51 BTC, which at the time would have bought me two pairs and express postage! This was at 10pm at night and I was tired, and so it happens, it take a few hours for the transfer to occur from your wallet to the SR wallet. So I went to sleep. In the morning the price has plunged.

I waited for a little while, hoping the BTC value would come back up somewhere near the price I bought them for. But this didn’t look likely anytime soon, so I bought myself 1 pair (note, not the 2 I was going to get!) and express postage, for .75 BTC. The process essentially involved typing my name and address and confirming the order. FoxyGirl offers buyers the option of encrypting the address details using her public key for extra protection. As I am not buying an illegal item, I was happy to use my actual name and actual address and not to encrypt. To me, this is the weakest link of the system for the buyer (who is purchasing an illegal item) – they must decide what to do. It seems a lot of people who buy drugs on SR do ship to their real name and real address: I guess there is more chance it will arrive that way as long as Customs or the Post do not detect contraband in the package. But there is a lottery involved here – some packages do get checked and do get detained. In Australia it appears the odds of having a package detected is a bit higher than in other parts of the world.

I’ve had further messages with FoxyGirl to nominate what colour and size I would like, and now she is processing my order. Another custom to be aware of in SR transactions is ‘finalising’. Once the order moves from processing to in transit, as the buyer, I will have the option to ‘finalise’ which indicate the package has arrived and the vendor can receive their money from the SR escrow. As I am a first-time buyer and from Australia, there’s a high chance that I will be asked to finalise early, which means to press that finalise button before the vendor will ship the product. The rules on SR state that no-one should finalise early because then all the risk is transferred from the vendor to the buyer, but many top vendors request FE to protect themselves against buyer fraud. In my case, FoxyGirl had no requirement to FE, so I’ll do it the SR approved way. But in my browsing of drug listings, many top vendors selling MDMA or cannabis or cocaine require FE for Australians or for buyers with no history or negative history.

Now I just have to wait and see when (if?) my package arrives!


Update 29/4/13: my package arrived this morning and the goods all check out. Looks very legit. The slightly concerning part was that I was asked to sign for the goods. I’m sure most people buying from SR wouldn’t be so keen to sign for their package. Other than that, all went well.

Australia’s newest response to emerging psychoactive drugs

Having followed this issue closely and recently published an article in The Conversation outlining the various policy responses Australia might consider in response to emerging psychoactive drugs, I was surprised to read about the passing of new commonwealth legislation amending the Criminal Code 1995 in The Age yesterday.

Link to new legislation

Link to explanatory document

Link to call for public comment

Link to parliamentary readings and timeline for passing of bill

From these documents, we see that the first reading of the bill occurred on 10 October, a period of public comment was available from 11 to 26 October, the bill was passed to Senate on 30 October. It was introduced to the Senate on 31 October and passed on 21 November.

While all this was happening, I was focusing on providing evidence to the NSW Inquiry into new synthetic drugs, with no idea of the development and public consultation period of this other important legislation. While clearly I need to be better informed, I also think the Commonwealth should consider increasing public awareness and the capacity for the public to input into this area, as the NSW Inquiry has done.

Moving onto the legislation…

While I’m not a lawyer and have only read the bill once (disclaimer: don’t rely on me for legal advice!), this is the bit I think is the most important to consider:

“301.13 Emergency determinations—serious drugs
(1) The Minister may, by legislative instrument, determine that:
(a) a substance, other than a growing plant, is a controlled drug or a border controlled drug; or
(b) a growing plant is a controlled plant or a border controlled plant.
(2) The Minister must not make a determination under subsection (1) unless he or she is satisfied:
(a) that there is an imminent and substantial risk that the substance or plant will be taken without appropriate medical supervision; and
(b) one or more of the following conditions is met:
(i) taking the substance or plant may create a risk of death or serious harm;
(ii) taking the substance or plant may have a physical or mental effect substantially similar to that caused by taking a listed serious drug;
(iii) there is limited or no known lawful use of the substance or plant in Australia, and the substance or plant has been found by a public official in the course of the performance of the official’s duties;
(iv) the substance or plant may pose a substantial risk to the health or safety of the public.
(3) The Minister must not make more than one determination under this section in relation to a particular substance or plant.”

Initial questions that arise after reading this paragraph for me are:
–    Are we now in Australia going to have new drugs controlled entirely at discretion of parliamentary ministers?
–    Section 2-b-ii If the new substance has an effect ‘substantially similar’ to that caused by a prohibited drug will be enough to ban it… even if it causes substantially less harm whilst still producing a similar psychoactive effect?
–    Section 2-b Only one of these conditions needs to be met?

“301.17 Emergency determinations—publication
(1) The Minister must, on or before the day on which a determination under this Subdivision is registered (within the meaning of the Legislative Instruments Act 2003):
(a) make a public announcement of the determination; and
(b) cause a copy of the announcement to be published:
(i) on the internet; and
(ii) in a newspaper circulating in each State, the Australian Capital Territory and the Northern Territory.”

My interpretation – folks will have absolutely no warning about said emergency determinations. No grace period for suppliers or users to remove these items from shelves or from their houses.

What I don’t understand is how will this legislative changes interact with State/Territory legislation. How will it be applied outside of federal jurisdictions? Any comments or thoughts on this issue would be appreciated.

Our federal response has gone in the opposite direction of our counterparts in New Zealand, who have proposed a regulatory model to deal with new psychoactive drugs.

While the NZ scheme would allow for the scenario of a lower risk alternative drug being legally available to use, the Australian response appears to assume that ANY substances that produces substantially similar effects to currently prohibited substances must be banned.

The problem is obvious to me. While there is no formal recognition of the functions and benefits of drugs that cannot be classed as formally ‘medical’ (that is, to get high, to enjoy oneself, to relax, to achieve personal insights, to explore altered conscious states), it is consistent to ban any substance with substantially similar effects to those currently prohibited.

Until our society can accept the critical importance of altering conscious states for human beings (and indeed many other animal species), we will fail* in our attempts to regulate emerging psychoactive substances.

* My definition of ‘fail’ may be different from yours or the government’s – I believe we have failed if our policies actually result in more rather than less drug-related harm.

Some would argue that if these new laws reduce access to emergent drugs, thereby reducing use, then less harm is produced. My hunch, however, is that access will continue, but our information about what is in these products and what we should advise people who choose to use them will be even more limited than it currently is. If my hunch is correct, we will be inducing more harm and providing less and less control.

We will also have to wait and see how these laws will play out in practice and when interacted with other legislative instruments.

I may be wrong on any of the above, so please correct me in the comments. Your input is greatly appreciated.


Synthetic cannabinoids in Australia: an update

Stephen Bright and I recently posted an update to our popular post from November 2011 on The Conversation. It is reprinted in full below:

Synthetic cannabis is a lab-made product that mimics the effects of cannabis to give users a high when smoked. It has been sold in Australia since 2011 under various brand names, with a range of chemical compositions.

The product presents a unique challenge for drug policymakers. Despite 18 months of legislative action intended to ban synthetic cannabis, people in some states claim [mp3] they can still walk into a sex store or tobacconist and purchase it. Clearly the legislative changes have not been totally effective.

Who uses synthetic cannabis in Australia?

Last month, we published findings from the first survey of synthetic cannabis users in Australia.

When we asked people why they had first used synthetic cannabis, its legal status was an important reason. While 39% stated that they first tried the product because it was legal, 23% mentioned its availability was important, and 8% mentioned its non-detection in drug testing as a key factor.

We also found that almost all synthetic cannabis users who participated in our study had previously or were currently using cannabis.

Furthermore, evidence from this study and from the wider literature (for example, by Christopher Hoyte and Maren Hermanns-Clausen) indicates that synthetic cannabis products may be as risky as or more risky than cannabis itself. This is due to the lack of information about the ingredients in synthetic cannabis products and the pharmacological profiles of different synthetic cannabis varieties. We have virtually no information about longer term effects of these drugs.

The current state of regulation

A year ago, we published a summary of the legal status of synthetic cannabinoids in Australia. Since then, the Therapeutic Goods Administration (TGA) enacted new laws that prohibited eight broad classes of synthetic cannabinoids as well as any drugs that mimic cannabis.

These laws were intended to capture synthetic cannabinoids that were yet to be identified or even synthesised, in order to put an end to the cat and mouse game, where manufacturers introduce a new product immediately after legislators prohibit an old one.

Despite the TGA laws being ratified six months ago, there does not appear to have been any prosecutions of manufacturers based on these laws to date.

While importation falls under federal legislation, most drug laws are state-based. And while the relevant legislation in some states such as Victoria refers to the TGA’s legislation, the drug laws in other states such as New South Wales do not.

Our advice from law enforcement representatives in these states suggests that prosecution using the TGA’s legislation can only occur in federal jurisdictions (such as border control) and requires involvement by federal agents.

Nonetheless, even in Victoria – where some stores have reportedly had their synthetic cannabis confiscated since the TGA’s laws were ratified – it is unclear whether charges will be laid. Until charges are laid and these cases tried, the impact of the new laws remains unclear.

In another development, Queensland moved to independently implement new legislation redefining a “dangerous drug” as anything intended to “have a substantially similar pharmacological effect” to a banned substance.

But this legislation was not ratified, which meant that Queensland police eventually dropped charges against a number of retailers whose synthetic cannabis was confiscated.

Assessing the regulatory options

Given the ambiguity regarding synthetic cannabis, a NSW parliamentary committee is assessing the regulatory options for newer synthetic drugs. Last month, the committee heard evidence from government officials, industry representatives and researchers.

We outlined the following five possible regulatory options for the committee, while also recognising that the evidence to guide decision-making is limited.

The first is to continue banning individual substances as they become known. This option results in legislation and services playing catch up to an ever increasing array of new substances. A risk is that it may contribute to more harm by driving newer and lesser known products onto the market.

The second regulatory option is to ban broad categories of substances, including ones that activate the same brain systems as currently prohibited substances. But these broader laws have so far not been successfully prosecuted. They also assume that drugs of a similar category or that act on similar parts of the brain have similar harm profiles, when this may or may not be the case.

The third is to use currently available laws for the regulation of medicinal or consumer products, as some experts recently suggested. While this option may have merit, it offers only limited control.

The fourth option is to follow New Zealand’s lead and implement a specific regulatory regime for new psychoactive substances. Under the proposed system, distributors will be required to establish the safety of their products at their own expense before they may be legally sold. This new regulatory regime offers an alternative policy response to mitigate against the harmful cycle of new, untested drugs being sold as “legal highs”, but its success is yet to be established.

The fifth option is to design a new legislative framework that regulates all psychoactive substances. This option is consistent with recent calls for drug law reform. However, the Gillard government has indicated that it will not consider this option, and we still know very little about what the supply, use and harms of synthetic cannabis would look like if cannabis were legally available.

Even though there is no clear evidence to guide policy making in this area, we do know that the emergence of newer synthetic drugs is a complex challenge that requires consideration of all available policy options. We await the recommendations from the NSW Inquiry, due in 2013, which are likely to guide the direction of both state and commonwealth policy reform.

The drug’s in the mail

Last week was a week of firsts for me: first time mentioned in The Age, first time a photo of me was printed in The Age, first time I have spoken on radio (3AW) and first time I’ve appeared on national television (The Project, Network Ten). As regular readers of this blog will know, I’ve done a bit of media training but haven’t had much of a chance to put it into practice. Now at least I’ve done these things once, I’ll have a better chance of preparing and understanding what’s required for next time 🙂

Journalists who tackle drug stories often get a bad rap – they are often accused of sensationalist, one-sided reporting. I want to congratulate the journalists I worked with on these stories as I feel they represented my views accurately. While there is always a dose more ‘drama’ in these stories than I am comfortable with, I don’t think these stories were over sensationalised and they were largely accurate in their reporting. So, thanks to the journalists involved. Looking forward to working with you again in future.

Read The Age article: original link, archived link.

Listen to the 3AW radio segment: original link, archived link.

Watch The Project: original link (it’s after the ‘global news’ segment), archived link.

The internet poses unique challenges for drug prohibition

Following is my article published at The Conversation yesterday. It’s a summary of my current work based on my recent presentation which you can view on vimeo if you prefer audio-visual 🙂

The Australia21 report argues the “war on drugs” has failed and we should consider other options for controlling drugs, such as decriminalisation or regulation. In addition to these arguments, an important challenge for drug prohibition has been overlooked in the drugs debate so far: the internet.

While the internet has opened up new opportunities to buy drugs, it has also accelerated new drug trends. In the past year, we’ve seen the emergence of two key trends: synthetic cannabinoids (sold as Kronic, K2, Spice, among other names) and the anonymous online marketplace Silk Road.

What are synthetic cannabinoids?

Synthetic cannabinoids are drugs that mimic the effects of cannabis. They are typically sold as a smokeable herb mixture which has been sprayed with synthetic cannabinoid chemicals and then dried. They first appeared internationally around 2004 and became the focus of increased media and regulatory attention in Australia in 2011.

Research into the harms of these products is in its infancy, but early reports suggest some synthetic cannabinoids may be more likely to produce paranoia and adverse cardiovascular problems than cannabis itself.

The internet is used to sell these products, as Googling the word Kronic will show you. Nevertheless, preliminary results from our yet-to-be-published survey of 316 synthetic cannabinoid users found that only 22% bought from online stores. Most preferred to buy from bricks-and-mortar stores such as herbal high shops, adult shops and tobacconists.

Comparisons of Google search statistics with our survey data suggest a link between the discussion of synthetic cannabinoids in online news, online searches for synthetic cannabinoids, and reports from survey respondents of when they first tried the drug. Increased media coverage of synthetic cannabis seems to pique public and drug user interest in these substances, which leads to further media interest in an iterative cycle.

Policy responses under prohibition

Various Australian states and territories, as well as the federal Therapeutic Goods Administration, legislated against specific synthetic cannabinoids during 2011. In response, manufacturers have attempted to get around these laws by creating new blends which they claim are legal.

It is still too early to tell whether soon-to-be-enacted federal laws – prohibiting eight broad categories of synthetic cannabinoids and any drugs that claim to mimic cannabis – will effectively end this cat-and-mouse game.

Silk Road

Silk Road is like an eBay for illicit drugs. All kinds of substances are available, including heroin, ecstasy, methamphetamine and cannabis. Similarly to eBay, buyers rate sellers and provide comments about the quality of their products, how fast they ship, and their level of professionalism and discretion.

Silk Road is accessible only to people who are using Tor anonymising software. Tor uses encryption which aims to make it impossible for anyone to trace the internet user’s IP address. Buyers and sellers on Silk Road also use the encrypted currency Bitcoin, which is supposed to prevent the financial transactions from being traced.

Australian buyers may be concerned about the potential for customs to discover the illicit contents of the package they receive in the mail. But discussions in the Silk Road forum suggest that Australians are using Silk Road to buy from both overseas and Australian sellers.

There is a lot we don’t know about Silk Road and other similar marketplaces. My colleagues and I will soon begin a pilot study to better understand how Silk Road works.

Policy responses under prohibition

It’s unclear whether any policy responses to control Silk Road have been effective.

One approach is to try to regulate overseas internet content through the proposed internet filter. But I doubt it will have any effect on Silk Road because it operates in what is known as the “hidden web”.

The second approach is to ban the technologies that make Silk Road work: Tor and Bitcoin. This does not appear to be possible because both are peer-to-peer technologies and it’s hard to imagine how such a ban could be enforced.

The third is to increase scanning of posted letters and parcels. But while scanning of the parcel post has been increased over recent years, it’s not clear how effective such measures are and what impact they have on the speed of the postal system.

The fourth is for law enforcement to infiltrate Silk Road to gather intelligence. This is probably already occurring. We’re yet to see whether such law enforcement measures are capable of disrupting the Silk Road market.

It’s becoming increasingly clear that synthetic drugs and online anonymous drug marketplaces pose unique challenges for drug prohibition. Policy makers must keep these challenges in mind when considering alternative ways to control and regulate drugs.

Making academic knowledge media friendly

I attended a 2 day seminar last week run by the Centre for Research Excellence into Injecting Drug Use (CREIDU, or ‘cree-du’). The centre was launched mid-2011 and is based at the Burnet Institute, Melbourne. Day one focused on how to deal with the media. Day two focused on translating research into policy, and was run by the Drug Policy Modelling Program (DPMP). The program was an excellent mix of perspectives and practice. For my own benefit and for anyone else who is reading, I thought it would be useful to summarise what I learnt from the workshop.

Tracy Parish, Deputy Head of Public Affairs and Communications at Burnet, showed us this video (an advert for The Guardian) to illustrate how stories can spiral outwards in our contemporary media landscape:

We got a good sense of the journalist’s perseptive on science/academics. The journalist’s role is to ‘decipher complex issues’. They need to synthesise information into small digestible chunks and usually they need to do this to a hard deadline. Journalists need news that hooks the reader in. Why should the reader care about our academic findings? We need to have a solid answer to this question prior to engaging the media on our issue.

A great tool for seeing whether we can front the media effectively is the dinner party test – can you fascinate a group of non-specialists with a short story about what you do? Or do they back away as soon as you utter your first sentence? Why should your parents’ friends care about what you do? What connection would they make with your work?

I really enjoyed the presentation by Jon Faine, Radio presenter of the ABC morning show in Victoria. His presentation style was captivating which I think illustrated his main point, that you are performing when you engage with the media and you need to tell a good story. He also noted that ‘the media’ is often described as one monolithic entity, but that commercial and non-commercial media have completely different mandates and practices which we should be aware of when we choose who to engage with and how. Regardless of what kind of media we are talking about, Jon’s message of ‘head, heart, hip’ is important – if the story can’t be directly related to the head, heart or hip pocket of the audience, it’s not a compelling story.

For the rest of this post, I’m simply going to list the tips I wrote down from the entire day – which came from a number of diverse speakers and audience members.

When dealing with the media, academics should…

  • tell a good anecdote because this will engage the audience (allowing them to ‘paint a picture’ of the issue)
  • avoid statistics although simple numbers/proportions are compelling if they are limited in number and go to the core of the issue
  • don’t assume any prior knowledge – this can be difficult for academics who mainly socialise with other academics, but think about the dinner party test (I was thinking about times when I found myself talking to my parents’ neighbours about my phd!)
  • use the word ‘you’ and ‘your’, eg. in your workplace, in your family, in your community (why should the audience care about this story if it does not relate directly to them?)
  • if you are taking a purely ‘evidence-based’ approach and are asked your personal opinion, you can say that you have an opinion but that it doesn’t matter because your role is only to provide the evidence (further discussion occurred regarding advocacy positioning)
  • stick to your stance and if the journalist continues to push against you, suggest they go to another organisation and if you know of a suitable one, name them
  • never say just ‘yes’ or ‘no’, the journalist is looking for quotes so you need to speak in sentences
  • you can say no to a request from the media – it is good to remember that journalists need content to survive and that you are actually helping them to do their job, so you can be in charge of it – whether to do it in the first place, where to do it, when to do it, etc.

Specific advice for when you are preparing for or engaged in a phone interview with a journalist (eg. for newspaper):

  • Ask how long the interview will be? Remember you are likely only to be quoted for one sentence or two at the most so you need to prepare those messages.
  • Prepare a cheat sheet of 1-3 messages and any numbers/facts you need to get right
  • Research the journalist and publication if you don’t already know them well. What other pieces has this journalist written/produced? What standard of work are they associated with?
  • It was suggested that you should ensure the journalist understands that if they are not prepared to show you the article prior to publication, you are not prepared to allow them to use your name. I have personally found that journalists feel this request questions their integrity and their ability to do their job, and can get defensive, so I’m not sure whether this request is appropriate in practice. The best solution to this problem is probably around cultivating long-term relationships with journalists (see below).
  • Stand up! Wear heals/more formal clothing – find a place that is less familiar than your office to conduct the phone call. These actions help you to remember during the interview that this is not a casual conversation, this is a formal performance. It is easy to lapse into casual conversation which is when you are most likely to sway away from your defined role in this process.

Advice for managing your overall engagement with media:

  • Jon Faine described the OMDB (Over My Dead Body) list. If a journalist does the wrong thing by you, don’t deal with them again. Have a white list and a black list which you cultivate over time. Don’t reward bad behaviour.
  • Cultivate long-term relationships with journalists and media organisations. Doing this reduces your chances of being misquoted or misrepresented because the journalist will value their relationship with you and not want to jeopardise it if possible. It means you have a list of people to go to when you do have a story you think is newsworthy who you are not ‘cold-calling’.
  • During your academic research, be on the look out for good visual opportunities – video or image – and record them as you go. These can be used later for media engagements. If you provide visuals, you are more likely to reach a television audience – without visuals, you are limited to radio and newspapers.


  • Some journalists read conference abstracts and may follow up with academics from this material. While this practice may not be commonplace, it is therefore good practice to ensure that conference abstracts are not only written for the academic community but also contain media friendly messages – assuming you want to attract media attention to your story (you don’t always want this!).
  • Approach the media liaison at a conference and introduce yourself to them.

Alternatives to media engagement

  • Write it yourself as an opinion piece – this way you can’t be misquoted or misrepresented

The final message? You need to first decide whether you want to be an academic that engages with the media. If you don’t want to, you need to communicate your findings to someone who will do it for you. If you do want to engage, you need to commit to learning how to do it well. This takes a regular time commitment and needs to be factored into your job timelines. It may mean that one less academic paper gets written per annum or it may mean the media-engaged researcher has to do more overtime. A major problem the workshop identified was that academics don’t get rewarded adequately for community engagement. Will the media-engaged researcher with slightly less academic publications win a fellowship over the media-disengaged researcher with slightly more academic publications? I hope that public impact count for something and I think it should definitely count for more than it does now.

Should academics engage with the media? Even if they will sometimes get it wrong (or oftentimes get it wrong depending on who you ask)? I say yes, we must. When it comes to evidence-based drug policy, we have an obligation to make our evidence appealing to the public. Public opinion matters more and more in terms of what policies governments are prepared to implement. If we can’t persuade governments, we may need to take on public opinion to have an impact on drug policy.